Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice
Mycobacterium tuberculosis (Mtb) remains a global health challenge due to the limited efficacy of the Mtb vaccine in current use, Bacillus Calmette–Guérin (BCG). To date, there is no available vaccine for immunocompromised individuals. Thus, there is an urgent need to develop a new vaccine candidate...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2018-02-01
|
| Col·lecció: | Frontiers in Cellular and Infection Microbiology |
| Matèries: | |
| Accés en línia: | http://journal.frontiersin.org/article/10.3389/fcimb.2018.00031/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|